A user increased their dutasteride dose to 2.5 mg and oral minoxidil to 5 mg after losing hair regrowth, and also started using 2% ketoconazole and microneedling. Another user suggested these changes are meaningful and recommended splitting doses throughout the day for better absorption.
A 23-year-old man with hairloss, despite using dutasteride, oral minoxidil, and RU58841, is considering bicalutamide for regrowth but is concerned about feminization. Alternatives like topical estrogen, JXL069, and spironolactone are discussed, with suggestions to explore thyroid levels and other potential underlying conditions.
GT20026 is discussed as a potential treatment for hairloss that targets androgen receptors without affecting hormone levels, but it may not promote significant regrowth. It is expected to be available by 2028, with other treatments like Breezula and Clascoterone also mentioned.
A user is considering a topical hairloss treatment containing Minoxidil, Finasteride, and other ingredients. Some users suggest the doses are high and recommend starting with lower percentages.
Serevelle is being considered for hairloss due to menopause, but its effectiveness is unclear. Minoxidil and hormone management are suggested alternatives.
A clinical trial in Australia offers $20,000 for participation, aiming to regrow hair and reverse grey hair. Participants must not have used hair treatments recently and must visit a Melbourne clinic regularly over 18 months.
Finasteride and dutasteride are discussed as preventative treatments for hairloss, with some advocating for early use and others concerned about side effects, especially before full maturity. Many regret not starting these treatments earlier due to their effectiveness in preventing or slowing hairloss.
Creatine is believed by some to cause hairloss, potentially by increasing DHT levels, despite conflicting evidence. Users report mixed results when combining creatine with treatments like finasteride, dutasteride, and minoxidil.